Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Wiewrodt

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
The European Respiratory Journal|June 2, 2018
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancerJan-Henrik Mikesch, Daniela Schwammbach, Wolfgang Hartmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
European Journal of Haematology|March 29, 2017
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literatureArik Bernard Schulze, Britta Heptner, Torsten Kessler, et al.
Plos One|October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancerLars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genesAntje Hascher, Ann-Kristin Haase, Katja Hebestreit, et al.
Oncogene|December 8, 2020
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migrationChunhong Cui, Yi Liu, Dennis Gerloff, et al.
International Journal of Cancer|February 24, 2015
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancerEtmar Bulk, Anne-Sophie Ay, Mehdi Hammadi, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
The European Respiratory Journal|June 2, 2018
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancerJan-Henrik Mikesch, Daniela Schwammbach, Wolfgang Hartmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.
Plos One|August 28, 2015
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined SubgroupsLars Henning Schmidt, Andreas Kümmel, Dennis Görlich, et al.
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
European Journal of Haematology|March 29, 2017
Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: A case report and review of the literatureArik Bernard Schulze, Britta Heptner, Torsten Kessler, et al.
Plos One|October 28, 2017
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancerLars Henning Schmidt, Birthe Heitkötter, Arik B Schulze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genesAntje Hascher, Ann-Kristin Haase, Katja Hebestreit, et al.
Oncogene|December 8, 2020
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migrationChunhong Cui, Yi Liu, Dennis Gerloff, et al.
International Journal of Cancer|February 24, 2015
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancerEtmar Bulk, Anne-Sophie Ay, Mehdi Hammadi, et al.
Pageof 7